Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study-Reference-Cited by-同舟云学术

Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study

Published:2014-05 Issue:6 Volume:15 Page:620-630
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Corrie Pippa G,Marshall Andrea,Dunn Janet A,Middleton Mark R,Nathan Paul D,Gore Martin,Davidson Neville,Nicholson Steve,Kelly Charles G,Marples Maria,Danson Sarah J,Marshall Ernest,Houston Stephen J,Board Ruth E,Waterston Ashita M,Nobes Jenny P,Harries Mark,Kumar Satish,Young Gemma,Lorigan Paul

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

2. Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis;Mocellin;JNCI,2010

3. Angiogenesis inhibitors: current strategies and future prospects;Cook;CA Cancer J Clin,2010

4. Angiogenesis in cancer, vascular, rheumatoid and other disease;Folkman;Nat Med,1995

5. Role of angiogenesis in tumor growth and metastasis;Folkman;Semin Oncol,2002

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entering the TiME machine: How age-related changes in the tumor immune microenvironment impact melanoma progression and therapy response;Pharmacology & Therapeutics;2024-10

2. Unaddressed Challenges in the Treatment of Cutaneous Melanoma?;Medicina;2024-05-28

3. Neuro-ophthalmic complications of modern anti-cancer drugs;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-02-12

4. Mechanistic and Clinical Chemoprevention;Reference Module in Biomedical Sciences;2024

5. Efficacy and safety of immune checkpoint inhibitors and targeted therapies in resected melanoma: a systematic review and network meta-analysis;Frontiers in Pharmacology;2023-11-07